DETERMINING TRANSDUCER LOCATIONS FOR DELIVERY OF TUMOR TREATING FIELDS USING SIMULATIONS BASED ON MODELS OF HEALTHY SUBJECTS
A method for determining transducer locations for delivery of tumor treating fields based on models of healthy subjects, including: receiving a medical image of a subject having an abnormality; receiving a selection of a healthy model from a plurality of healthy models, the healthy model being representative of the subject, the selection based on the medical image of the subject; receiving a selection of locations on the healthy model to place transducers to treat the abnormality of the subject without identifying a location of the abnormality in the healthy model; receiving an indication of a region of interest in the healthy model; and calculating for each of the locations, a dosage of tumor treating fields treatment in the region of interest of the healthy model without modifying the healthy model to include abnormal tissue.
1 . A computer-implemented method for determining transducer locations for delivery of tumor treating fields based on models of healthy subjects, the method comprising:
receiving a medical image of a subject having an abnormality;
receiving a selection of a healthy model from a plurality of healthy models, the healthy model being representative of the subject, the selection based on the medical image of the subject;
receiving a selection of locations on the healthy model to place transducers to treat the abnormality of the subject without identifying a location of the abnormality in the healthy model;
receiving an indication of a region of interest in the healthy model; and
calculating, by at least one processor, for each of the locations, a dosage of tumor treating fields treatment in the region of interest of the healthy model without modifying the healthy model to include abnormal tissue.
2 . The method of claim 1 , wherein the selection of the healthy model is based on identifying a landmark in the medical image of the subject and a corresponding landmark in the healthy model.
3 . The method of claim 1 , wherein the selection of the healthy model comprises:
determining a plurality of measurements of the subject from the medical image of the subject;
comparing the plurality of measurements of the subject to a plurality of measurements for each health model; and
selecting the healthy model being representative of the subject as the healthy model having measurements most similar to measurements of the subject.
4 . The method of claim 3 , wherein the selection of the healthy model is further based on a location of an organ of the subject.
5 . The method of claim 1 , wherein the selection of the locations on the healthy model to place transducers to treat the abnormality is based at least in part on conductivities for at least one tissue type included in the healthy model.
6 . The method of claim 5 , wherein calculating the dosage of tumor treating fields treatment is based at least in part on the conductivities for the at least one tissue type included in the healthy model.
7 . The method of claim 1 , wherein the healthy model defines healthy tissue having an electrical property, wherein calculating the dosage of treatment is based at least in part on the electrical property.
8 . The method of claim 1 , wherein each of the plurality of healthy models is segmented based on tissue type.
9 . The method of claim 1 , wherein each of the plurality of healthy models is representative of a group of the healthy subjects without abnormalities.
10 . The method of claim 1 , wherein the plurality of healthy models is based on the healthy subjects clustered into groups.
11 . The method of claim 1 , wherein the plurality of healthy models are generated by:
receiving training data for the healthy subjects;
analyzing the training data to identify commonalities among the healthy subjects;
clustering the healthy subjects into clusters based at least in part on the commonalities among the healthy subjects; and
generating the plurality of healthy models, wherein the generating comprises, for each cluster, generating one of the plurality of healthy models based at least in part on the training data for the healthy subjects that are within the cluster.
12 . The method of claim 11 , wherein generating the plurality of healthy models comprises selecting, for each cluster, a model of one of the healthy subjects within the cluster to be the healthy model.
13 . The method of claim 11 , wherein generating the plurality of healthy models comprises generating, for each cluster, the healthy model using information about at least two of the healthy subjects within the cluster.
14 . The method of claim 11 , wherein each of the healthy subjects has a medical image associated therewith, wherein measurements for each healthy subject are extracted from the medical image associated with each healthy subject.
15 . The method of claim 11 , wherein analyzing the training data comprises performing a principal component analysis to identify the commonalities among the plurality of healthy subjects.
16 . The method of claim 11 , wherein the commonalities are based on principal components defined for each of the healthy subjects.
17 . The method of claim 16 , wherein the clustering is performed using k-means clustering.
18 . The method of claim 1 , wherein the medical image is at least one of a computed tomography (CT) image, a magnetic resonance imaging (MRI) medical image, or a positron emission tomography (PET) medical image.
19 . An apparatus for determining transducer locations for delivery of tumor treating fields based on models of healthy subjects, the apparatus comprising:
one or more processors; and
a memory accessible by the one or more processors, the memory storing instructions that when executed by the one or more processors, cause the apparatus to:
receive a medical image of a subject having an abnormality;
receive a selection of a healthy model from a plurality of healthy models, the healthy model being representative of the subject, the selection based on the medical image of the subject;
receive a selection of locations on the healthy model to place transducers to treat the tumor of the subject without identifying a location of the abnormality in the healthy model;
receive an indication of a region of interest in the healthy model; and
calculate a dosage of tumor treating fields treatment in the region of interest of the healthy model without modifying the healthy model to include abnormal tissue associated with the abnormality.
20 . A non-transitory processor readable medium containing a set of instructions thereon for determining transducer locations for delivery of tumor treating fields based on models of healthy subjects, wherein when executed by a processor, the instructions cause the processor to:
receive a medical image of a subject having an abnormality;
receive a selection of a healthy model from a plurality of healthy models, the healthy model being representative of the subject, the selection based on the medical image of the subject;
receive a selection of locations on the healthy model to place transducers to treat the tumor of the subject without identifying a location of the abnormality in the healthy model;
receive an indication of a region of interest in the healthy model; and
calculate a dosage of tumor treating fields treatment in the region of interest of the healthy model without modifying the healthy model to include abnormal tissue associated with the abnormality.